Ronald G. Jubin
Hoofd Techniek/Wetenschap/O&O bij Prolong Pharmaceuticals LLC
Profiel
Ronald G.
Jubin is currently the Vice President of Research & Development at Prolong Pharmaceuticals LLC since 2013.
Prior to this, he worked as a Principal at Schering-Plough Research Institute.
He holds a doctorate degree from New Jersey Medical School.
Actieve functies van Ronald G. Jubin
Bedrijven | Functie | Begin |
---|---|---|
Prolong Pharmaceuticals LLC
Prolong Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ. | Hoofd Techniek/Wetenschap/O&O | 18-12-2013 |
Eerdere bekende functies van Ronald G. Jubin
Bedrijven | Functie | Einde |
---|---|---|
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Opleiding van Ronald G. Jubin
New Jersey Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Prolong Pharmaceuticals LLC
Prolong Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |